ChemoCentryx Inc (OQ:CCXI)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CCXI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 12/20 May 12/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -35,865 $57.75
May 12/20 May 12/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 35,865 $14.31
May 12/20 May 12/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -35,865  
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -70,608  
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -16,029 $56.14
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -54,579 $55.33
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 70,608 $14.31
May 12/20 May 11/20 Cappel Markus J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,222  
May 12/20 May 11/20 Cappel Markus J. Direct Ownership Common Stock S - Open market or private sale -34,222 $55.11
May 12/20 May 11/20 Cappel Markus J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,222 $3.57
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CCXI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -70,608  
May 12/20 May 8/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -4,201  
May 12/20 May 12/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -35,865 $57.75
May 12/20 May 12/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 35,865 $14.31
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -16,029 $56.14
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -54,579 $55.33
May 12/20 May 11/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 70,608 $14.31
May 12/20 May 8/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -4,201 $55.01
May 12/20 May 12/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -35,865  
May 12/20 May 8/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,201 $14.31
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CCXI

Competitors

Competitors with Recent Insider Filings
Allakos (OQ:ALLK)
BioMarin Pharmaceutical (OQ:BMRN)
Apellis Pharmaceuticals (OQ:APLS)